MYOK - MyoKardia Inc.
Previous close
224.91
0 0%
Share volume: 0
Last Updated: Mon 16 Nov 2020 06:00:00 AM CET
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$224.91
0.00
0.00%
Summary score
35%
Profitability
58%
Dept financing
3%
Liquidity
50%
Performance
16%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.12%
Return on assets
-6.37%
Return on sales
0%
Return on invested capital
-93.36%
Total debt ratio
15.03%
Debt ratio change over timeo
-0.99%
Current Ratio
9.2%
Quick Ratio
0%
Cash Position Ratio
7%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.83%
Return on assets
-12.07%
Return on sales
0%
Return on invested capital
-7.47%
Total debt ratio
13.61%
Debt ratio change over timeo
-1.02%
Current Ratio
12.57%
Quick Ratio
0%
Cash Position Ratio
6.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7%
Return on assets
-6.47%
Return on sales
0%
Return on invested capital
-214.76%
Total debt ratio
9.02%
Debt ratio change over time
-1.05%
Current Ratio
21.03%
Quick Ratio
0%
Cash Position Ratio
14.99%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.64%
Return on assets
-97.82%
Return on sales
0%
Return on invested capital
31.2%
Total debt ratio
-99.16%
Debt ratio change over time
-0.99%
Current Ratio
-6.41%
Quick Ratio
0%
Cash Position Ratio
-5.26%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | MYOK | MDCO | ARQL | PTLA |
---|---|---|---|---|
Return on equity | -7.12% | -82.7% | -28.34% | -794.78% |
Return on assets | -6.37% | -6.39% | -11.32% | -16.7% |
Return on sales | 0% | -592.81% | 0% | -826.43% |
Return on invested capital | -93.36% | -39.78% | 65.69% | -104.81% |
Profitability | 75% | 0% | 25% | 0% |
Total debt ratio | 15.03% | 89.22% | 39.55% | 60.57% |
Debt ratio change over time | -0.99% | -8.16% | -0.59% | -0.79% |
Dept financing | 4% | 25% | 36% | 17% |
Current Ratio | 12.57% | 0.77% | 8.27% | 5.09% |
Quick Ratio | 0% | 0% | 0% | 5.05% |
Cash Position Ratio | 6.67% | 0.63% | 2.73% | 2.71% |
Liquididy | 50% | 27% | 26% | 50% |
Short-term ratios | MYOK | MDCO | ARQL | PTLA |
---|---|---|---|---|
Return on equity | -13.83% | 124.28% | -7.01% | -64.42% |
Return on assets | -12.07% | -6.93% | -6.25% | -11.38% |
Return on sales | 0% | 0% | 0% | -213.56% |
Return on invested capital | -7.47% | -50.2% | -29.16% | -220.69% |
Profitability | 50% | 25% | 25% | 0% |
Total debt ratio | 13.61% | 106.64% | 15.09% | 75.55% |
Debt ratio change over time | -1.02% | -10.07% | -0.85% | -0.84% |
Dept financing | 3% | 25% | 4% | 43% |
Current Ratio | 12.57% | 0.77% | 8.27% | 5.09% |
Quick Ratio | 0% | 0% | 0% | 5.05% |
Cash Position Ratio | 6.67% | 0.63% | 2.73% | 2.71% |
Liquididy | 50% | 4% | 27% | 45% |